Similar articles

• [Pheochromocytoma and paraganglioma: basics for the general practitioner].

  Loosli N, Köhler BB, Pechère-Bertschi A, Karenovics W, Triponex F. Loosli N, et al. Rev Med Suisse. 2014 Sep 10;10(441):1650-2, 1654-5. Rev Med Suisse. 2014. PMID: 25322623 Review. French.
• [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].

  Jochmanová I, Lazúrová I. Jochmanová I, et al. Vnitr Lek. 2017 Fall;63(9):580-588. Vnitr Lek. 2017. PMID: 29120654 Czech.
• Clinical evaluation and treatment of phaeochromocytoma.

  Davison AS, Jones DM, Ruthven S, Helliwell T, Shore SL. Davison AS, et al. Ann Clin Biochem. 2018 Jan;55(1):34-48. doi: 10.1177/0004563217739931. Epub 2017 Nov 8. Ann Clin Biochem. 2018. PMID: 29027806 Review.
• [Recent advances in adrenal diseases].

  Gruber M, Eisenhofer G, Fassnacht M, Bornstein SR. Gruber M, et al. Dtsch Med Wochenschr. 2011 Oct;136(40):1998-2001. doi: 10.1055/s-0031-1286379. Epub 2011 Sep 28. Dtsch Med Wochenschr. 2011. PMID: 21960326 Review. German. No abstract available.
• Phaeochromocytomas and functional paragangliomas: clinical management.

  Plouin PF, Amar L, Lepoutre C. Plouin PF, et al. Best Pract Res Clin Endocrinol Metab. 2010 Dec;24(6):933-41. doi: 10.1016/j.beem.2010.10.002. Best Pract Res Clin Endocrinol Metab. 2010. PMID: 21115162